Epileptic seizure prediction plays a crucial role in enhancing the quality of life for individuals with epilepsy. Over recent years, a multitude of deep learning-based approaches have emerged to tackle this challenging task, leading to significant advancements. However, the 'black-box' nature of deep learning models and the considerable interpatient variability significantly impede their interpretability and generalization, thereby severely hampering their efficacy in real-world clinical applications. To address these issues, our study aims to establish an interpretable and generalizable seizure prediction model that meets the demands of clinical diagnosis. Our method extends self-interpretable prototype learning networks into a novel domain adaptation framework designed specifically for cross-patient seizure prediction. The proposed framework enables patient-level interpretability by tracing the origins of significant prototypes. For instance, it could provide information about the seizure type of the patient to which the prototype belongs. This surpasses the existing sample-level interpretability, which is limited to individual patient samples. To further improve the model's generalization capability, we introduce a contrastive semantic alignment loss constraint to the embedding space, enhancing the robustness of the learned prototypes. We evaluate our proposed model using the Freiburg intracranial electroencephalography (iEEG) dataset, which consists of 20 patients and a total of 82 seizures. The experimental results demonstrated a high sensitivity of 79.0%, a low false prediction rate of 0.183, and a high area under the receiver operating characteristic curve (AUC) value of 0.804, achieving state-of-the-art performance with self-interpretable evidence in contrast to the current cross-patient seizure prediction methods. Our study represents a significant step forward in developing an interpretable and generalizable model for seizure prediction, thereby facilitating the application of deep learning models in clinical diagnosis.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.compbiomed.2024.109257 | DOI Listing |
Disabil Rehabil
January 2025
Murdoch Children's Research Institute, The University of Melbourne, Melbourne, Australia.
Purpose: The range of impairments in children with neurodisability (ND) complicates data collection, yet individualising materials and procedures could enable more children to self-report. This study introduces the Cognitive Accessibility Tracking Questionnaire (CATQ), designed to monitor changes enhancing accessibility ("adaptations") in interview-administered patient-reported outcome measures (PROMs). The CATQ is used in a longitudinal study of mental health and participation in children with ND investigating adaptation use and its utility in assessing the risk of bias introduced by these adaptations.
View Article and Find Full Text PDFNeurosci Bull
January 2025
Key Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province, School of Pharmaceutical Sciences, College of Pharmaceutical Sciences, The Second Affiliated Hospital of Zhejiang Chinese Medical University (Xinhua Hospital), Zhejiang Chinese Medical University, Hangzhou, 310053, China.
Approximately 30%-40% of epilepsy patients do not respond well to adequate anti-seizure medications (ASMs), a condition known as pharmacoresistant epilepsy. The management of pharmacoresistant epilepsy remains an intractable issue in the clinic. Its early prediction is important for prevention and diagnosis.
View Article and Find Full Text PDFBehav Neurol
January 2025
Department of Pediatric Psychology, College of Medicine, Balcalı Hospital, Çukurova University, Adana, Turkey.
According to the International League Against Epilepsy (ILAE) 2015 classification, status epilepticus (SE) is a seizure that lasts longer than 5 min or a frequency of more than one seizure within 5 min, without returning to a normal level of consciousness between episodes. In this study, we aimed to evaluate the prognostic factors of SE and compare our patients with those of patients treated internationally with the modified status epilepticus severity score (mSTESS) to determine the reliability of this scoring system. The medical records of patients aged 1 month-17 years with SE who were treated at Çukurova University-Balcalı Training and Research Hospital between September 2018 and September 2021 and who were followed in the intensive care unit were included in the study.
View Article and Find Full Text PDFPak J Med Sci
January 2025
Lamei Yuan, MD, PhD, Health Management Center, the Third Xiangya Hospital, Disease Genome Research Center, Center for Experimental Medicine, the Third Xiangya Hospital, Research Center of Medical Experimental Technology, the Third Xiangya Hospital, Xiangya School of Medicine, Central South University, Changsha 410013, Hunan, China.
Objective: To identify the disease-causing variant in a family with tuberous sclerosis complex (TSC).
Methods: This study including a Han-Chinese pedigree recruited from the Third Xiangya Hospital, Central South University, Changsha, Hunan, China was conducted between February, 2019 and January, 2023. Detailed clinical examinations were performed on the proband and other family members of a Han-Chinese family with TSC.
Clin Neurophysiol
January 2025
Department of Neurosurgery, The University of Iowa, Iowa City, IA 52242, USA; Iowa Neuroscience Institute, The University of Iowa, Iowa City, IA 52242, USA.
Objectives: (1) Gain insight into the mechanisms of postoperative delirium (POD). (2) Determine mechanistic overlap with post-ictal delirium (PID). Epilepsy patients undergoing intracranial electrophysiological monitoring can experience both POD and PID, and thus are suitable subjects for these investigations.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!